T2/FLAIR不匹配与弥散受限作为儿童中央被盖束高信号MRI评估的新型病理生理标志物
回顾性分析2011年7月至2022年1月3462例儿童脑MRI,识别104例双侧中央被盖束高信号(CTTH)患者,评估T2/FLAIR不匹配与弥散受限及其与临床诊断的关系。结果显示60.4%存在T2/FLAIR不匹配,40.8%存在弥散受限,39.6%有FLAIR高信号;T2/FLAIR不匹配与临床诊断显著相关(p=.020),弥散受限与T2/FLAIR不匹配显著相关(p=.017)。作者认为CTTH可能源于短暂发育现象或不可逆髓鞘变性的病理过程,上述两个标志物提供有价值的诊断信息,需进一步研究验证。
要点
- 儿童双侧CTTH中60.4%出现T2/FLAIR不匹配,40.8%出现弥散受限,39.6%有FLAIR高信号。
- T2/FLAIR不匹配与临床诊断显著相关(p=.020),弥散受限与T2/FLAIR不匹配显著相关(p=.017)。
- T2/FLAIR不匹配与弥散受限可能提示CTTH的严重程度与慢性程度。
核心结论
- 儿童CTTH可能源于两种不同过程:短暂的发育现象或不可逆髓鞘变性的病理过程;T2/FLAIR不匹配和弥散受限提供有价值的诊断标志物,反映CTTH的严重程度与慢性程度,需进一步研究验证这些发现及其临床意义。
研究设计与样本
- 回顾性分析2011年7月至2022年1月3462例儿童脑MRI扫描,识别104例双侧CTTH患者,年龄1个月至16岁(平均31.34个月),视觉评估DWI、FLAIR序列及随访扫描中的T2/FLAIR不匹配和弥散受限,临床数据来自电子病历,使用SPSS进行统计分析,显著性设定为p<.05。
关键影像表现/征象
- CTTH表现为T2加权成像上中央被盖束高信号,本研究评估其与FLAIR、DWI序列的关系。
- 60.4%的患者存在T2/FLAIR不匹配(首次在CTTH中定义)。
- 40.8%的患者观察到弥散受限,39.6%的患者有FLAIR高信号。
诊断标准与关键数值
- T2/FLAIR不匹配在CTTH中首次定义,见于60.4%的患者。
- 弥散受限见于40.8%的患者,FLAIR高信号见于39.6%的患者。
- T2/FLAIR不匹配与临床诊断显著相关(p=.020)。
- 弥散受限与T2/FLAIR不匹配显著相关(p=.017)。
- 癫痫、代谢性疾病和脑性瘫痪是最常见的临床诊断。
临床应用与阅片要点
- 在儿童脑MRI报告中评估CTTH时,可结合FLAIR和DWI序列判断是否存在T2/FLAIR不匹配和弥散受限。
- 作者认为T2/FLAIR不匹配和弥散受限可提供关于CTTH严重程度与慢性程度的诊断信息。
局限性
- 原文结论指出需进一步研究验证这些发现及其临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Central tegmental tract hyperintensity (CTTH) on T2-weighted imaging is an uncommon neuroimaging finding in pediatric patients with unclear clinical significance. CTTH may represent either a physiological or pathological process. This study evaluates the relationship between CTTH and MRI sequences (FLAIR, DWI) to explore its diagnostic value.
METHODS: We retrospectively analyzed 3462 pediatric brain MRI scans conducted between July 2011 and January 2022, identifying 104 patients with bilateral CTTH. DWI, FLAIR sequences, and follow-up scans were visually assessed for T2/FLAIR mismatch and diffusion restriction. Clinical data were obtained from electronic patient records. Statistical analysis was performed using SPSS, with significance set at p < .05.
RESULTS: A total of 104 pediatric patients with CTTH were included, ranging from 1 month to 16 years old (mean age: 31.34 months). Epilepsy, metabolic diseases, and cerebral palsy were the most common clinical diagnoses. Diffusion restriction was observed in 40.8% of patients, while 39.6% had FLAIR hyperintensity. T2/FLAIR mismatch, defined for the first time in CTTH, was found in 60.4% of patients. A significant correlation was found between T2/FLAIR mismatch and clinical diagnoses (p = .020), as well as between diffusion restriction and T2/FLAIR mismatch (p = .017).
CONCLUSION: CTTH in pediatric patients may arise from two distinct processes: a transient, developmental phenomenon or a pathological process marked by irreversible myelin degeneration. T2/FLAIR mismatch and diffusion restriction provide valuable diagnostic markers, offering insights into the severity and chronicity of CTTH. Further studies are needed to validate these findings and their clinical implications.
引用
- Buyukceran EU, Sahap SK, Genc S, et al. T2/FLAIR mismatch and diffusion restriction as novel pathophysiological markers in MRI evaluation of central tegmental tract hyperintensity in pediatric patients. Neuroradiology. 2024. PMID: 39570401. doi:10.1007/s00234-024-03509-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。